Singapore | 10 March 2023 | News
Digital health anchoring back to reality with slowdown of venture funding in 2022 in APAC
Galen Growth, the leading digital health, data-driven market intelligence company, and FINN Partners, a global...Read more
Pharma | 06 March 2023 | Analysis
The word layoff is accustomed to us and many companies across the globe take part in this exercise. Excuses li...Read more
Japan | 15 March 2023 | News
Takeda’s dengue vaccine receives first approval in Latin America
Japanese pharmaceutical company Takeda's dengue vaccine, QDENGA (Dengue Tetravalent Vaccine [Live, ...Read more
New Zealand | 13 March 2023 | News
Breakthrough neurological drug comes from New Zealand to treat Rett Syndrome
A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zeal...Read more
Japan | 08 March 2023 | News
Japan's Teijin Pharma inks $230 M deal with Novartis for kidney diseases treatment
Teijin Pharma, based in Japan, has entered into an exclusive global license agreement with Swiss firm ...Read more
Indonesia | 21 March 2023 | News
Indonesian startup Etana secures financing to strengthen oncology portfolio
PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical startup, has secured a new round o...Read more
Korea | 15 March 2023 | News
Korea's LG Chem to supply UNICEF with $200 M worth of essential vaccines
South Korean firm LG Chem has announced that it will supply essential vaccines, including polio vaccines, for ...Read more
Australia | 13 March 2023 | News
Monash University in Australia leads $15M mitochondrial donation clinical trial
Around 50 Australian children are born every year with devastating mitochondrial disease, with an expected lif...Read more
Singapore | 07 March 2023 | News
Singapore accelerates precision medicine through next-generation proteomics
The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS...Read more
Taiwan | 20 March 2023 | News
Taiwan approves new intraocular lens-based surgical implants for use in cataract treatment
AffaMed Technologies, a joint venture established between AffaMed Therapeutics and SIFI S.p.A., have announced...Read more
Singapore | 15 March 2023 | News
Singapore-based startup Qritive launches AI-powered prostate cancer diagnosis tool
Qritive, a leading provider of digital pathology solutions, has announced the launch of a new AI (Artific...Read more
Korea | 03 March 2023 | News
Korea develops nanoparticle-based deep brain stimulation therapy to treat Parkinson’s Disease
One of the various therapeutic approaches for neurodegenerative diseases such as Parkinson’s d...Read more
Australia | 01 March 2023 | News
Australian startup Microba unveils next-gen human gut microbiome tests
Microba Life Sciences, a startup based in Australia, has announced that it’s next generation testing pro...Read more
Korea | 17 March 2023 | News
Korea's Samsung Biologics invests over KRW 1.9 T in new facility
Samsung Biologics, a leading contract development and manufacturing organisation (CDMO) based in South Korea, ...Read more
China | 03 March 2023 | News
Startups in China accelerate development of gene and cell therapy
China-based startups Porton Advanced Solutions and DanausGT Biotechnology have announced a strategic coll...Read more
Singapore | 01 March 2023 | News
GenScript expands footprint in Singapore to provide premium gene synthesis service
GenScript Biotech Corporation has announced the expansion of its Singapore facility to provide a premium gene ...Read more
Australia | 15 February 2023 | News
Groundbreaking trial underway for treatment of advanced Retinitis Pigmentosa in Australia
In collaboration with US-based Kiora Pharmaceuticals, Inc. and The Royal Adelaide Hospital, leading Australian...Read more
HOW PLAUSIBLE IS ENDING TB SCOURGE?
Tuberculosis (TB) has been the leading cause of death from a single infectious agent, ranking above HIV/AIDS for a long time. And, presently, Asia Pacific is right in the thick of it. South-eastern Asia (SEA) is home to 26 per cent of the world’s population with a 43 per cent burden of TB incidence, according to the World Health Organisation’s (WHO) global TB report 2021. Over the last three years, countries around the world, including in Asia and the Pacific, have faced double pandemics –COVID-19 and TB. Unfortunately, during this time, progress toward TB elimination stalled and, in some cases, reversed. COVID-19 made it harder for people to access TB diagnostics and care, eading to increases in cases and deaths since 2019. Four countries, India, Indonesia, the Philippines, and Myanmar accounted for most of the estimated increase in TB deaths, globally, in 2021. Not all is lost though. The countries in the region, especially India and Indonesia, have renewed their efforts to eliminate TB. India launched the TB Free India campaign – a plan to eliminate tuberculosis by 2025, five years ahead of the target set by the UN’s sustainable development goals. Indonesia received a $300 million loan from the World Bank to improve overage, quality and efficiency of TB response in the country. When observing World TB day this year on March 24, let’s take stock of the progress made by Asian countries in eliminating this dreaded disease and the way forward.
For Feedback Email Us: communications@biospectrumasia.com
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
+65 90150305
